KYVTHREE
Dead / Abandoned — Abandoned — failure to respond (as of 30 Nov 2023)
What this means for you
This application is over — abandoned 17 Nov 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97660238
- Mark type
- Stylized text
- Filed
- 02 Nov 2022
- Abandoned
- 17 Nov 2023
- Attorney of record
- Lisa Greenwald-Swire
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease
Owner
- Kyverna Therapeutics, Inc., Emeryville, CA, US
Prosecution history
- 30 Nov 2023 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 30 Nov 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 30 Nov 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 16 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 16 Aug 2023 — NON-FINAL ACTION E-MAILED
- 16 Aug 2023 — NON-FINAL ACTION WRITTEN
- 16 Aug 2023 — ASSIGNED TO EXAMINER
- 07 Nov 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 05 Nov 2022 — NEW APPLICATION ENTERED